File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Development and pre/post testing of a decision aid supporting Chinese parental and young women’s HPV vaccination decision-making

TitleDevelopment and pre/post testing of a decision aid supporting Chinese parental and young women’s HPV vaccination decision-making
Authors
KeywordsCervical cancer
decision aid
decisional conflict
decision self-efficacy
Human papillomavirus (HPV)
Issue Date2020
PublisherTaylor & Francis (Routledge): SSH Titles. The Journal's web site is located at http://www.tandfonline.com/loi/wwah20#.VP9HKfldX5E
Citation
Women & Health, 2020, v. 60 n. 3, p. 330-340 How to Cite?
AbstractWe developed and tested the acceptability and utility of a novel HPV vaccination decision aid (DA) among Chinese young women aged 18–26 years and parents of adolescent girls aged 9–17 years. From March to May 2016, a total of 101 parents plus 109 young women completed baseline surveys assessing their HPV vaccination knowledge, decision self-efficacy, decision conflict, and HPV vaccination intention. Two weeks after receiving the DA, 84 (83.2%) parents and 92 (84.4%) young women completed re-assessments. Chi-square tests or t-tests were performed to compare the before-and-after differences. Cohen’s d was calculated to indicate the effect size. After reading the DA, both participating young women’s and parents’ knowledge of HPV vaccination (Cohen’s d = 0.62 among young women and d = 0.59 among parents) and decision self-efficacy (d = 0.38 among young women and d = 0.59 among parents) significantly increased. Both young women’s and parents’ decision conflict (d = −0 · 98 and −1.06) significantly decreased. The proportion of young women intending to receive HPV vaccination and parents deciding to vaccinate daughters against HPV significantly increased (p < 0 · 0001). The DA showed good acceptability and utility facilitating HPV vaccination decision-making for most Chinese young women and parents of adolescent girls. Further randomized controlled trials of this tool are essential.
Persistent Identifierhttp://hdl.handle.net/10722/281152
ISSN
2023 Impact Factor: 1.2
2023 SCImago Journal Rankings: 0.507
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWang, LD-L-
dc.contributor.authorLam, WWT-
dc.contributor.authorFielding, R-
dc.date.accessioned2020-03-09T09:50:53Z-
dc.date.available2020-03-09T09:50:53Z-
dc.date.issued2020-
dc.identifier.citationWomen & Health, 2020, v. 60 n. 3, p. 330-340-
dc.identifier.issn0363-0242-
dc.identifier.urihttp://hdl.handle.net/10722/281152-
dc.description.abstractWe developed and tested the acceptability and utility of a novel HPV vaccination decision aid (DA) among Chinese young women aged 18–26 years and parents of adolescent girls aged 9–17 years. From March to May 2016, a total of 101 parents plus 109 young women completed baseline surveys assessing their HPV vaccination knowledge, decision self-efficacy, decision conflict, and HPV vaccination intention. Two weeks after receiving the DA, 84 (83.2%) parents and 92 (84.4%) young women completed re-assessments. Chi-square tests or t-tests were performed to compare the before-and-after differences. Cohen’s d was calculated to indicate the effect size. After reading the DA, both participating young women’s and parents’ knowledge of HPV vaccination (Cohen’s d = 0.62 among young women and d = 0.59 among parents) and decision self-efficacy (d = 0.38 among young women and d = 0.59 among parents) significantly increased. Both young women’s and parents’ decision conflict (d = −0 · 98 and −1.06) significantly decreased. The proportion of young women intending to receive HPV vaccination and parents deciding to vaccinate daughters against HPV significantly increased (p < 0 · 0001). The DA showed good acceptability and utility facilitating HPV vaccination decision-making for most Chinese young women and parents of adolescent girls. Further randomized controlled trials of this tool are essential.-
dc.languageeng-
dc.publisherTaylor & Francis (Routledge): SSH Titles. The Journal's web site is located at http://www.tandfonline.com/loi/wwah20#.VP9HKfldX5E-
dc.relation.ispartofWomen & Health-
dc.rightsPreprint: This is an Author's Original Manuscript of an article published by Taylor & Francis Group in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/doi/abs/[Article DOI]. Postprint: This is an Accepted Manuscript of an article published by Taylor & Francis Group in [JOURNAL TITLE] on [date of publication], available online at: http://www.tandfonline.com/doi/abs/[Article DOI].-
dc.subjectCervical cancer-
dc.subjectdecision aid-
dc.subjectdecisional conflict-
dc.subjectdecision self-efficacy-
dc.subjectHuman papillomavirus (HPV)-
dc.titleDevelopment and pre/post testing of a decision aid supporting Chinese parental and young women’s HPV vaccination decision-making-
dc.typeArticle-
dc.identifier.emailWang, LD-L: lindawdl@connect.hku.hk-
dc.identifier.emailLam, WWT: wwtlam@hku.hk-
dc.identifier.emailFielding, R: fielding@hku.hk-
dc.identifier.authorityLam, WWT=rp00443-
dc.identifier.authorityFielding, R=rp00339-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/03630242.2019.1626791-
dc.identifier.pmid31195899-
dc.identifier.scopuseid_2-s2.0-85067547059-
dc.identifier.hkuros309292-
dc.identifier.volume60-
dc.identifier.issue3-
dc.identifier.spage330-
dc.identifier.epage340-
dc.identifier.isiWOS:000472390900001-
dc.publisher.placeUnited States-
dc.identifier.issnl0363-0242-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats